This article was first published by the Duke Center for Applied Genomics and Precision Medicine

Speculation that a vaccine for COVID-19 might be widely available by the end of this year is overly optimistic, three Duke experts said Wednesday.

Duke’s MURDOCK Study has launched a COVID-19 research project to follow the health of hundreds of North Carolina volunteers for several months. The study will also test a sub-group for COVID-19 infection and potential immunity to the novel coronavirus that causes the disease.

Duke doctors brief media on how best to move forward in the pandemic

If you’re in public and see someone wearing a mask, that person is doing it for your benefit.

More resources and health protections are critical to protect Hispanic communities – many filled with essential workers – during the ongoing pandemic, three Duke health experts said Wednesday.

See all talks from Duke researchers and Durham community partners on the forum website.

The virus’s ability to change makes it likely that new human coronaviruses will arise

Test sees the antibodies that would grant immunity to COVID-19 – if it occurs

A trio of researchers at Duke University School of Medicine who have long collaborated to study how the immune system’s antibodies respond to HIV infection are now focusing on the new coronavirus.

Even before the COVID-19 epidemic Latinx immigrants were a vulnerable population.